Per Medbøe Thorsby (f. 1964) er ph.d., seksjonsoverlege og medisinskfaglig ansvarlig ved Hormonlaboratoriet, Oslo universitetssykehus. Han er medlem av medisinsk fagkomité i Antidoping Norge og sitter som ekspert innen endokrinologi i European Medicines Agency (EMA).
Forfatter har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.
Glerup H, Mikkelsen K, Poulsen L et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000; 66: 419 – 24. [PubMed] [CrossRef]
Wang TJ, Zhang F, Richards JB et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376: 180 – 8. [PubMed] [CrossRef]
4.
Johansson H, Odén A, Kanis J et al. Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos Int 2012; 23: 991 – 9. [PubMed] [CrossRef]
5.
Holick MF. The D-lightful vitamin D for health. Journal of Medical Biochemistry 2013; 32: 1 – 58. [CrossRef]
6.
Holick MF. Vitamin D and the skin: photobiology, physiology and therapeutic efficacy for psoriasis. Amsterdam: Elsevier, 1990.
7.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477 – 501. [PubMed] [CrossRef]
8.
Kamao M, Tatematsu S, Sawada N et al. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites. J Steroid Biochem Mol Biol 2004; 89 – 90: 39 – 42. [PubMed] [CrossRef]
9.
Singh RJ, Taylor RL, Reddy GS et al. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006; 91: 3055 – 61. [PubMed] [CrossRef]
10.
Bailey D, Veljkovic K, Yazdanpanah M et al. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013; 46: 190 – 6. [PubMed] [CrossRef]
11.
Meyer HE, Falch JA, Søgaard AJ et al. Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway. The Oslo Health Study. Bone 2004; 35: 412 – 7. [PubMed] [CrossRef]
12.
Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911 – 30. [PubMed] [CrossRef]
13.
Jorde R, Sneve M, Torjesen PA et al. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50: 175 – 80. [PubMed] [CrossRef]
14.
Hathcock JN, Shao A, Vieth R et al. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6 – 18. [PubMed]
15.
Vitenskapskomiteen for mattrygghet. Assessment of vitamin A and D in food supplements. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety. Oslo: Vitenskapskomiteen for mattrygghet (VKM), 2013.
16.
Souberbielle J-C, Courbebaisse M, Cormier C et al. When should we measure Vitamin D concentration in clinical practice? Scand J Clin Lab Invest Suppl 2012; 243: 129 – 35. [PubMed]
17.
Janssen MJW, Wielders JPM, Bekker CC et al. Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids 2012; 77: 1366 – 72. [PubMed] [CrossRef]
Får du ikke vist PDF-filen eller vil lagre filen, kan du høyreklikke på PDF-ikonet. Velg «Lagre mål/fil som..» og hent så opp PDF-filen i for eksempel Acrobat Reader.